That is, TLR4 and C5aR1 represent an alternative upstream regulator in activating NF-κB by inhibiting cAMP/PKA signals and participate in TNF-α, IL-1β, and IL-6 production in MCAO/R-induced brain injury. Here, IL6 is linked to brain injury.